F.D.A. to Relabel Leucovorin for Autism Treatment
PositiveScience

The F.D.A. has announced a significant update to the labeling of leucovorin, indicating its potential benefits in alleviating symptoms of autism. This change is important as it opens new avenues for treatment options for individuals with autism, providing hope for families seeking effective therapies.
— Curated by the World Pulse Now AI Editorial System